CompletedNot Applicable

Monitoring Spondyloarthritis With SpA-Net

Netherlands200 participantsStarted 2020-12-02

Plain-language summary

Randomized controlled trial to assess the effectiveness and cost-effectiveness of an intervention combining patient initiated care and telemonitoring through the online eHealth platform SpA-Net versus standard care for patients with spondyloarthritis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patient (18+ years) * Diagnosis of SpA according to treating physician * At least 2 years of disease duration, to be familiar with signs, symptoms, and medication * Stable disease, defined as being in a patient acceptable symptom state according to patient AND treating physician AND no treatment change expected in the next few months * Access to a computer, tablet and/or smartphone for the entire duration of the study Exclusion Criteria: * Insufficient mastery of Dutch language * Incompetent to act for oneself * Limited life expectancy * Ongoing (or planned) pregnancy during the study period * Patients participating in other research project(s)

What they're measuring

Number of scheduled and unscheduled outpatient visits to the rheumatology department.

Timeframe: 1 year

Trial details

NCT IDNCT04673825

SponsorMaastricht University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-01

View on ClinicalTrials.gov More Spondyloarthritis trials